Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	16.18	23.87	20.55
Graham Fair Price	-62.69	3833.58	10273.81
PEG	-43.57	0.35	-0.62
Price/Book	1011.33	1.30	0.12
Price/Cash Flow	515.85	183.85	29.85
Prices/Earnings	-13.97	13.32	15.48
Price/Sales	20.97	4.34	3.58
Price/FCF	515.85	183.85	29.85
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	4.87	0.37	0.36
Operating Margin	-0.62	0.11	0.11
ROA	1201.90	0.02	< 0.005
ROE	< 0.005	0.02	1191.79
ROIC	< 0.005	0.02	756.16
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	-0.03	87.55
Dividends QOQ	-1.00	759.18	75916.51
EBIT QOQ	0.03	-0.05	79.34
EPS QOQ	-0.25	0.38	52.47
FCF QOQ	0.27	-0.81	204.42
Revenue QOQ	0.02	-0.05	163.57
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	108.82	127.25	16.93
Days Sales Outstanding (DSO)	76.82	82.98	8.02
Inventory Turnover	0.83	0.71	-14.48
Debt/Capitalization	0.02	0.13	723.74
Quick Ratio	1.33	1.35	0.98
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	49739.21	5163.87	-89.62
Cash	1074.11	982.34	-8.54
Capex	-150.46	-151.16	-0.47
Free Cash Flow	195.63	36.65	-81.27
Revenue	1629.52	1554.21	-4.62
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.13	2.24	4.86
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	0.53	0.83	56.23
Naive Interpretation	Member

06 - Financial Health · Bad

Rating